Iterum Therapeutics plc (ITRMF) Cash flow
Market cap
$764K
P/E ratio
| 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 1 | 2 | 3 | 4 | 5 | 1 | 0 |
| Cash from operations | -76 | -79 | -55 | -16 | -18 | -39 | -27 |
| Capital expenditures | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Cash from investing | -9 | 40 | -0 | -55 | 14 | 23 | 18 |
| Proceeds from issuance of term debt, net | - | - | 1 | - | - | - | - |
| Repayments of term debt | - | 1 | 6 | 7 | 2 | - | - |
| Cash from financing | 121 | -1 | 64 | 83 | -2 | 1 | 27 |
| Free cash flow | |||||||
| FCF margin (%) | - | - | - | - | - |